Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Frank Maldarelli

Showing results (71-80 of 137) with videos related to

Pageof 14
Sort By:
Iscience|December 11, 2025
Targeted bacteriophage T4 nanoparticles reverse HIV-1 latency in human T cell line modelsHimanshu Batra, Jingen Zhu, Swati Jain, et al.
Antimicrobial Agents and Chemotherapy|November 1, 2021
A Combination of Amino Acid Mutations Leads to Resistance to Multiple Nucleoside Analogs in Reverse Transcriptases from HIV-1 Subtypes B and CPaul L Boyer, Catherine A Rehm, Michael C Sneller, et al.
Ebiomedicine|July 20, 2025
CD4 T cell counts are inversely correlated with anti-gp120 cluster A antibodies in antiretroviral therapy-treated PLWHMehdi Benlarbi, Jonathan Richard, Tommaso Clemente, et al.
Retrovirology|February 14, 2013
Analysis of 454 sequencing error rate, error sources, and artifact recombination for detection of Low-frequency drug resistance mutations in HIV-1 DNAWei Shao, Valerie F Boltz, Jonathan E Spindler, et al.
AIDS (London, England)|December 23, 2008
Inferiority of IL-2 alone versus IL-2 with HAART in maintaining CD4 T cell counts during HAART interruption: a randomized controlled trialBrian O Porter, Kara B Anthony, Jean Shen, et al.
AIDS (London, England)|July 18, 2022
High-level dolutegravir resistance can emerge rapidly from few variants and spread by recombination: implications for integrase strand transfer inhibitor salvage therapyKristi Huik, Shawn Hill, Jomy George, et al.
Pediatrics|August 23, 2006
Tenofovir disoproxil fumarate and an optimized background regimen of antiretroviral agents as salvage therapy: impact on bone mineral density in HIV-infected childrenRachel I Gafni, Rohan Hazra, James C Reynolds, et al.
Blood Advances|December 22, 2018
Safety and efficacy of an oncolytic viral strategy using bortezomib with ICE/R in relapsed/refractory HIV-positive lymphomasErin G Reid, David Looney, Frank Maldarelli, et al.
Pediatrics|November 18, 2005
Tenofovir disoproxil fumarate and an optimized background regimen of antiretroviral agents as salvage therapy for pediatric HIV infectionRohan Hazra, Rachel I Gafni, Frank Maldarelli, et al.
Plos One|February 25, 2012
Multiple sources of contamination in samples from patients reported to have XMRV infectionMary F Kearney, Jonathan Spindler, Ann Wiegand, et al.
Pageof 14

Showing results (71-80 of 137) with videos related to

Sort By:
Pageof 14
Iscience|December 11, 2025
Targeted bacteriophage T4 nanoparticles reverse HIV-1 latency in human T cell line modelsHimanshu Batra, Jingen Zhu, Swati Jain, et al.
Antimicrobial Agents and Chemotherapy|November 1, 2021
A Combination of Amino Acid Mutations Leads to Resistance to Multiple Nucleoside Analogs in Reverse Transcriptases from HIV-1 Subtypes B and CPaul L Boyer, Catherine A Rehm, Michael C Sneller, et al.
Ebiomedicine|July 20, 2025
CD4 T cell counts are inversely correlated with anti-gp120 cluster A antibodies in antiretroviral therapy-treated PLWHMehdi Benlarbi, Jonathan Richard, Tommaso Clemente, et al.
Retrovirology|February 14, 2013
Analysis of 454 sequencing error rate, error sources, and artifact recombination for detection of Low-frequency drug resistance mutations in HIV-1 DNAWei Shao, Valerie F Boltz, Jonathan E Spindler, et al.
AIDS (London, England)|December 23, 2008
Inferiority of IL-2 alone versus IL-2 with HAART in maintaining CD4 T cell counts during HAART interruption: a randomized controlled trialBrian O Porter, Kara B Anthony, Jean Shen, et al.
AIDS (London, England)|July 18, 2022
High-level dolutegravir resistance can emerge rapidly from few variants and spread by recombination: implications for integrase strand transfer inhibitor salvage therapyKristi Huik, Shawn Hill, Jomy George, et al.
Pediatrics|August 23, 2006
Tenofovir disoproxil fumarate and an optimized background regimen of antiretroviral agents as salvage therapy: impact on bone mineral density in HIV-infected childrenRachel I Gafni, Rohan Hazra, James C Reynolds, et al.
Blood Advances|December 22, 2018
Safety and efficacy of an oncolytic viral strategy using bortezomib with ICE/R in relapsed/refractory HIV-positive lymphomasErin G Reid, David Looney, Frank Maldarelli, et al.
Pediatrics|November 18, 2005
Tenofovir disoproxil fumarate and an optimized background regimen of antiretroviral agents as salvage therapy for pediatric HIV infectionRohan Hazra, Rachel I Gafni, Frank Maldarelli, et al.
Plos One|February 25, 2012
Multiple sources of contamination in samples from patients reported to have XMRV infectionMary F Kearney, Jonathan Spindler, Ann Wiegand, et al.
Pageof 14